Sordillo, P.P., Allaire, A., Bouchard, A., Salvail, D. and Labbe, S.M.: The complex lipid, SPPCT-800, reduces lung damage, improves pulmonary function and decreases pro-inflammatory cytokines in the murine LPS-induced acute respiratory distress syndrome (ARDS) model. Pharmaceutical Biology, 60(1), pp.1255-1263, 2022.
Bolger, G.T., Pucaj, K., Minta, Y.O. and Sordillo, P.: Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin. Biochemical Pharmacology, p.115251, 2022.
Greil, R., Greil-Ressler, S., Weiss, L., Schönlieb, C., Magnes, T., Radl, B., Bolger, G.T., Vcelar, B. and Sordillo, P.P.: A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer. Cancer chemotherapy and pharmacology 82(4): 695-706, 2018.
Bolger, G.T., Licollari, A., Tan, A., Bagshaw, R., Greil, R., Vcelar, B., Majeed, M. and Sordillo, P.P.: Intense uptake of liposomal curcumin by multiple myeloma cell lines: Comparison to normal lymphocytes, red blood cells and chronic lymphocytic leukemia cells. Anticancer research 39(3): 1161-1168, 2019.
Bolger, G.T., Licollari, A., Tan, A., Greil, R., Vcelar, B., Greil-Ressler, S., Weiss, L., Schönlieb, C., Magnes, T., Radl, B., Majeed, M. and Sordillo, P.P.: Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. Cancer chemotherapy and pharmacology 1(1): 1-11, 2018.
Hocking, A., Tommasi, S., Sordillo, P.P. and Klebe, S.: The safety and exploration of the pharmacokinetics of intrapleural liposomal curcumin. International journal of nanomedicine 15: 943, 2020.
Bolger, G.T., Licollari, A., Tan, A., Greil, R., Pleyer, L., Vcelar, B., Majeed, M. and Sordillo, P.P.: Distribution of curcumin and THC in peripheral blood mononuclear cells isolated from healthy individuals and patients with chronic lymphocytic leukemia. Anticancer research 38(1): 121-130, 2018.
Sordillo, L.A., Sordillo, P.P. and Helson, L.: Sphingosine kinase inhibitors as maintenance therapy for glioblastoma after ceramide-induced response. Anticancer Research 36(5): 2085-2095, 2016.
Sordillo, P.P., Sordillo, L.A. and Helson, L.: Bifunctional role of pro-inflammatory cytokines after traumatic brain injury. Brain Injury 30(9): 1043-1053, 2016.
Sordillo, P.P., Sordillo, L.A. and Helson, L.: The Kynurenine pathway: A primary resistance mechanism in patients with glioblastoma. Anticancer Research 37(5): 2159 -2171, 2017.
Sordillo, P.P., Sordillo, D.C., Helson, L.: The prolonged QT interval: Role of pro-inflammatory cytokines, reactive oxygen species and the ceramide and sphingosine-1 phosphate pathways. In Vivo 29(6): 619-636, 2015.
Sordillo, P.P. and Helson, L.: Curcumin and cancer stem cells: Curcumin has asymmetrical effects on cancer and normal stem cells. Anticancer Research 35(2): 599-614, 2015.
Sordillo, L.A., Sordillo, P.P., Budansky, Y., Pu, Y., Alfano, R.R.: Differences in fluorescence profiles from breast cancer tissues due to changes in relative tryptophan content via protein energy transfer: Tryptophan content correlates with histologic grade and tumor size but not lymph node metastases. J. Biomed. Opt. 19(12): 1-6, 2014.
Sordillo, P.P., Magill, G., Brenner, J., Cheng, E., Dosik, M. and Yagoda, A.: Cisplatin: A phase II evaluation in previously untreated patients with soft-tissue sarcomas. Cancer 59: 884-886, 1987.
Sordillo, P.P., Markowitz, R. and Hardy, W.D.: Search for evidence of feline leukemia virus infection in humans with leukemias, lymphomas, or soft-tissue sarcomas. J. Natl. Cancer Inst. 69: 333-337, 1982.
Sordillo, P.P., Epremian, B., Koziner, B., Lacher, M. and Lieberman, P.: Lymphomatoid granulomatosis: An analysis of clinical and immunologic characteristics. Cancer: 49: 2070-2076, 1982.
Sordillo, P.P., Hajdu, S.I., Magill, G.B. and Golbey, R.B.: Extraosseous osteogenic sarcoma: Review of 48 patients. Cancer 51: 727-734, 1983.
Sordillo, P.P. and Magill, G.B.: Phase II trial of methyl CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-strep) in patients with disseminated pancreatic carcinoma. Amer. J. Clin. Oncol. 5: 277-279, 1982.
Brenner, J., Sordillo, P.P. and Magill, G.B.: Malignant mesothelioma in children: Report of seven cases and review of the literature. Med. Ped. Oncol. 9: 367-373, 1981.
Brenner, J., Sordillo, P.P., Magill, G.B. and Golbey, R.B.: Malignant peritoneal mesothelioma: Review of 25 cases. Amer. J. Gastroenterol. 73: 311-315, 1981.
Sordillo, P.P., Chapman, R., Hajdu, S., Magill, G.B. and Golbey, R.B.: Lymphangiosarcoma. Cancer 48: 1674-1679, 1981.
Sordillo, P.P., Helson, L., Hajdu, S.I., Magill, G.B., Kosloff, C., Golbey, R.B. and Beattie, E.J.: Malignant schwannoma: Clinical characteristics, survival and response to therapy. Cancer 47: 2503 -2509, 1981.
Sordillo, P.P., Sagransky, D.M., Mercado, R. and Michelis, M.F.: Carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion, reversal by concomitant phenytoin therapy. Arch. Int. Med. 138: 299-301, 1978.
Bolger, G.T., Pucaj, K., Minta, Y.O. and Sordillo, P.: Relationship between the in vitro efficacy, pharmacokinetics and in vivo efficacy of curcumin. Biochemical Pharmacology, p.115251, 2022.
Greil, R., Greil-Ressler, S., Weiss, L., Schönlieb, C., Magnes, T., Radl, B., Bolger, G.T., Vcelar, B. and Sordillo, P.P.: A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer. Cancer chemotherapy and pharmacology 82(4): 695-706, 2018.
Bolger, G.T., Licollari, A., Tan, A., Bagshaw, R., Greil, R., Vcelar, B., Majeed, M. and Sordillo, P.P.: Intense uptake of liposomal curcumin by multiple myeloma cell lines: Comparison to normal lymphocytes, red blood cells and chronic lymphocytic leukemia cells. Anticancer research 39(3): 1161-1168, 2019.
Bolger, G.T., Licollari, A., Tan, A., Greil, R., Vcelar, B., Greil-Ressler, S., Weiss, L., Schönlieb, C., Magnes, T., Radl, B., Majeed, M. and Sordillo, P.P.: Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. Cancer chemotherapy and pharmacology 1(1): 1-11, 2018.
Hocking, A., Tommasi, S., Sordillo, P.P. and Klebe, S.: The safety and exploration of the pharmacokinetics of intrapleural liposomal curcumin. International journal of nanomedicine 15: 943, 2020.
Bolger, G.T., Licollari, A., Tan, A., Greil, R., Pleyer, L., Vcelar, B., Majeed, M. and Sordillo, P.P.: Distribution of curcumin and THC in peripheral blood mononuclear cells isolated from healthy individuals and patients with chronic lymphocytic leukemia. Anticancer research 38(1): 121-130, 2018.
Sordillo, L.A., Sordillo, P.P. and Helson, L.: Sphingosine kinase inhibitors as maintenance therapy for glioblastoma after ceramide-induced response. Anticancer Research 36(5): 2085-2095, 2016.
Sordillo, P.P., Sordillo, L.A. and Helson, L.: Bifunctional role of pro-inflammatory cytokines after traumatic brain injury. Brain Injury 30(9): 1043-1053, 2016.
Sordillo, P.P., Sordillo, L.A. and Helson, L.: The Kynurenine pathway: A primary resistance mechanism in patients with glioblastoma. Anticancer Research 37(5): 2159 -2171, 2017.
Sordillo, P.P., Sordillo, D.C., Helson, L.: The prolonged QT interval: Role of pro-inflammatory cytokines, reactive oxygen species and the ceramide and sphingosine-1 phosphate pathways. In Vivo 29(6): 619-636, 2015.
Sordillo, P.P. and Helson, L.: Curcumin and cancer stem cells: Curcumin has asymmetrical effects on cancer and normal stem cells. Anticancer Research 35(2): 599-614, 2015.
Sordillo, L.A., Sordillo, P.P., Budansky, Y., Pu, Y., Alfano, R.R.: Differences in fluorescence profiles from breast cancer tissues due to changes in relative tryptophan content via protein energy transfer: Tryptophan content correlates with histologic grade and tumor size but not lymph node metastases. J. Biomed. Opt. 19(12): 1-6, 2014.
Sordillo, P.P., Magill, G., Brenner, J., Cheng, E., Dosik, M. and Yagoda, A.: Cisplatin: A phase II evaluation in previously untreated patients with soft-tissue sarcomas. Cancer 59: 884-886, 1987.
Sordillo, P.P., Markowitz, R. and Hardy, W.D.: Search for evidence of feline leukemia virus infection in humans with leukemias, lymphomas, or soft-tissue sarcomas. J. Natl. Cancer Inst. 69: 333-337, 1982.
Sordillo, P.P., Epremian, B., Koziner, B., Lacher, M. and Lieberman, P.: Lymphomatoid granulomatosis: An analysis of clinical and immunologic characteristics. Cancer: 49: 2070-2076, 1982.
Sordillo, P.P., Hajdu, S.I., Magill, G.B. and Golbey, R.B.: Extraosseous osteogenic sarcoma: Review of 48 patients. Cancer 51: 727-734, 1983.
Sordillo, P.P. and Magill, G.B.: Phase II trial of methyl CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-strep) in patients with disseminated pancreatic carcinoma. Amer. J. Clin. Oncol. 5: 277-279, 1982.
Brenner, J., Sordillo, P.P. and Magill, G.B.: Malignant mesothelioma in children: Report of seven cases and review of the literature. Med. Ped. Oncol. 9: 367-373, 1981.
Brenner, J., Sordillo, P.P., Magill, G.B. and Golbey, R.B.: Malignant peritoneal mesothelioma: Review of 25 cases. Amer. J. Gastroenterol. 73: 311-315, 1981.
Sordillo, P.P., Chapman, R., Hajdu, S., Magill, G.B. and Golbey, R.B.: Lymphangiosarcoma. Cancer 48: 1674-1679, 1981.
Sordillo, P.P., Helson, L., Hajdu, S.I., Magill, G.B., Kosloff, C., Golbey, R.B. and Beattie, E.J.: Malignant schwannoma: Clinical characteristics, survival and response to therapy. Cancer 47: 2503 -2509, 1981.
Sordillo, P.P., Sagransky, D.M., Mercado, R. and Michelis, M.F.: Carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion, reversal by concomitant phenytoin therapy. Arch. Int. Med. 138: 299-301, 1978.